Cerny Milena, Dunet Vincent, Rebecchini Caterina, Hahnloser Dieter, Prior John, Sempoux Christine, Schmidt Sabine
Lausanne University Hospital, Diagnostic and Interventional Radiology.
Lausanne University Hospital, Institute of Pathology.
Nuklearmedizin. 2019 Feb;58(1):28-38. doi: 10.1055/a-0809-4670. Epub 2019 Feb 15.
To prospectively evaluate histological significance and predictive value of changes in apparent diffusion coefficient (ADC) and F-FDG PET/CT parameters in locally advanced rectal cancer (LARC) after neoadjuvant radiochemotherapy (RCT).
Twenty-one patients with untreated LARC underwent pre-RCT and post-RCT F-FDG PET/CT and diffusion-weighted magnetic resonance imaging (DW-MRI), followed by surgery. For both datasets, two readers measured the tumor SUVmax, SUVmean, MTV, TLG, ADCmin, ADCmean, and respective differences (∆SUVmax, ∆SUVmean, ∆MTV, ∆TLG, ∆ADCmin, ∆ADCmean) for the whole tumor. Tumor regression grade according to Mandard (TRGm), percentage of residual tumor cells and fibrosis were estimated by two pathologists in consensus. Relationship between parameters was assessed on stepwise multivariate regression analysis and ROC curve analysis to evaluate their performance and predict the treatment response.
Eighteen LARCs were analyzed. SUVmax and SUVmean decreased from 21.3 ± 8.9 to 9.3 ± 5.5 g/mL, (p = 0.0002) and 12.3 ± 5.1 to 5.4 ± 3.1 g/mL, (p = 0.0002), respectively, after RCT, whereas ADCmin and ADCmean increased from 396 ± 269 to 573 ± 313×10mm/s (p = 0.014) and 1159 ± 212 to 1355 ± 194×10mm/s (p = 0.0008), respectively. TRGm and percentage of residual tumor cells independently correlated with post-RCT SUVmean (β = 0.73 and β = 0.76, p < 0.001) and post-RCT SUVmax (β = 0.72 and β = 0.78, p < 0.001), whereas percentage of fibrosis independently correlated with ∆ADCmean (β = 0.38, p = 0.008). Post-RCT, SUVmax and SUVmean performed well in predicting TRGm < 3 and residual tumor cells ≤ 20 %. ΔADCmean predicted fibrosis > 70 % well.
Post-RCT SUVmean, SUVmax and ∆ADCmean are complementary parameters for respectively evaluating residual tumor burden and amount of fibrosis in LARC. However, only SUV independently correlated with TRGm.
前瞻性评估新辅助放化疗(RCT)后局部晚期直肠癌(LARC)表观扩散系数(ADC)和F-FDG PET/CT参数变化的组织学意义及预测价值。
21例未经治疗的LARC患者在RCT前和RCT后接受F-FDG PET/CT及扩散加权磁共振成像(DW-MRI)检查,随后进行手术。对于这两个数据集,两名阅片者测量了整个肿瘤的肿瘤SUVmax、SUVmean、MTV、TLG、ADCmin、ADCmean以及各自的差值(∆SUVmax、∆SUVmean、∆MTV、∆TLG、∆ADCmin、∆ADCmean)。两名病理学家共同评估根据Mandard标准的肿瘤退缩分级(TRGm)、残余肿瘤细胞百分比和纤维化情况。通过逐步多元回归分析和ROC曲线分析评估参数之间的关系,以评估其性能并预测治疗反应。
分析了18例LARC。RCT后,SUVmax和SUVmean分别从21.3±8.9降至9.3±5.5g/mL(p = 0.0002)和从12.3±5.1降至5.4±3.1g/mL(p = 0.0002),而ADCmin和ADCmean分别从396±269升至573±313×10mm/s(p = 0.014)和从1159±212升至1355±194×10mm/s(p = 0.0008)。TRGm和残余肿瘤细胞百分比与RCT后的SUVmean(β = 0.73和β = 0.76,p < 0.001)和RCT后的SUVmax(β = 0.72和β = 0.78,p < 0.001)独立相关,而纤维化百分比与∆ADCmean独立相关(β = 0.38,p = 0.008)。RCT后,SUVmax和SUVmean在预测TRGm < 3和残余肿瘤细胞≤20%方面表现良好。∆ADCmean在预测纤维化> 70%方面表现良好。
RCT后的SUVmean、SUVmax和∆ADCmean是分别评估LARC残余肿瘤负荷和纤维化程度的互补参数。然而,只有SUV与TRGm独立相关。